Drugs / Ad35-GRIN/ENV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00851383 | Mar 2009 → Aug 2011 | HIV infectious disease | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad35-GRIN/ENV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00851383 ↗ |
| Modality | Vaccine | “Ad35-GRIN/ENV HIV vaccine” NCT00851383 ↗ |
| Route | Intramuscular | “Ad35-GRIN/ENV (Ad35-GRIN and Ad35-ENV mixed in the same vial in equal proportions) or Ad35-GRIN was administered intramuscularly at 0 and 6 months.” PMID 22870265 ↗ Aug 2012 |